Yan Chen currently serves as the Executive Director of CMC Management at WuXi Biologics, focusing on end-to-end downstream bioprocess development for vaccines, recombinant proteins, and biologics. Prior to this role, Yan held several positions at WuXi Biologics, including Senior Director and Associate Director, as well as a position as Associate Director at Bristol-Myers Squibb. Their earlier experience includes work as an Associate Principal Scientist in Vaccine Process Development at Merck and a Research Scientist at VaxInnate Corporation. Yan is pursuing a B.S. at Beijing Normal University and a Ph.D. at the University of Rochester School of Medicine and Dentistry.
Location
Cranbury, United States